From October 1, 2022 to December 31, 2022, the company has repurchased 115,419 shares, representing 1.38% for $0.46 million. With this, the company has completed the repurchase of 137,526 shares, representing 1.64% for $0.66 million under the buyback announced on August 16, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 USD | +1.79% |
|
-5.02% | -28.62% |
Jun. 04 | Lumos Pharma, Inc. Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 | CI |
May. 15 | Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.62% | 18.1M | |
+37.76% | 51.12B | |
-7.47% | 39.4B | |
+37.72% | 38.48B | |
+11.93% | 26.36B | |
-11.17% | 26.22B | |
+16.45% | 20.96B | |
+45.05% | 14.02B | |
+33.13% | 12.49B | |
-3.46% | 11.61B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Tranche Update on Lumos Pharma, Inc.'s Equity Buyback Plan announced on August 16, 2022.